TECNOTREE
22.12.2022 11:36:36 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for 5G and cloud-native technology, announced the simultaneous rollout of their digital BSS solutions for telecom service providers across Middle East, Africa, and Europe with a combined total of over 100 million subscribers. The rollout was part of the customers’ large-scale digital BSS transformation with Tecnotree Digital Suite for enterprise-B2B and consumer-B2C businesses for some of the largest operator groups like MTN, STC, Zain Group, Omantel and a Provider in Western Europe.
Tecnotree’s 5G-Ready Digital suite implementation provides customers with a differentiated product and service offerings built on TMF Open API, ODA compliant Microservices driven architecture with cutting edge technologies to digitally enable our customers to create a market differentiator and provide a new age experience to the end subscribers. The program involves transforming the customers’ legacy business processes, products, services, and customer experience with a consultative and advisory-led approach to provide a refreshing new-age digital experience. The full digital stack deployment includes Lead & Prospect, Customer Life Cycle Management, Catalog driven Order Management, Resource & Inventory Management, Loyalty Management, Service Provisioning, and Mediation, Convergent and Wholesale Billing, Business Operations Dashboard, and Call Completion systems providing end-to-end digital Customer Experience.
Tecnotree’s 5G-ready digital BSS suite with AI/ML capabilities comprises a full range of business processes with a product catalogue driven customer engagement of digital journeys and microservices, that support customer lifecycle and revenue management. Tecnotree has an agile and open-source Digital BSS Stack which is cloud-native, Open Digital Architecture (ODA) compliant, and platinum certified by TM Forum for real-world Open API implementation standards.
“We are excited to announce Tecnotree’s many successful go-lives across the continents. With these achievements, Tecnotree is taking important steps towards expanding to a wider global market. It demonstrates our scalability for swift deployments and the capability to deliver customer expectations. Tecnotree with its award-winning products has successfully transformed several legacy systems, meeting the rapidly changing consumer demands with innovative new offerings, preparing them for the new monetization opportunities presented by 5G and IoT,” said Padma Ravichander, CEO of Tecnotree Corporation.
“We are proud to partner with global Telecom Service Providers to roll out a Differentiated Digital Experience to Business, IT, Operations, and end subscribers through a Collaborative Consultative and Business Value driven Agile delivery using our advanced Microservices Accelerator platform and automation suites to enable faster delivery and parallel launches," said Ramaseshan Subramanian, Vice President & Head of Global Delivery & Operations, Tecnotree. "Our multi-functional delivery teams are trained in the latest automation technologies to provide the Best-in-Class delivery in an agile customer-success driven approach and ensure zero-touch delivery across the continents."
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree is among the first companies in the world to be Platinum Certified by TM Forum Open API standards, and our agile and open-source Digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on Helsinki Nasdaq (TEM1V).
For more information, please visit www.tecnotree.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221222005173/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom